Ocrevus Ocrelizumab 300mg Injection
Introduction
Ocrevus (Ocrelizumab) 300mg injection is a revolutionary monoclonal antibody therapy designed for the treatment of multiple sclerosis (MS), particularly relapsing-remitting MS (RRMS) and primary progressive MS (PPMS). Ocrelizumab works by targeting CD20-positive B cells, a type of immune cell that contributes to nerve inflammation and damage in MS. By selectively depleting these B cells, Ocrevus helps slow disease progression, reduce relapses, and manage neurological symptoms effectively.
Contact Details to Place Order:
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
Composition and Content
Each 300mg vial of Ocrevus contains:
Active Ingredient: Ocrelizumab 300mg
Excipients: L-histidine, L-histidine hydrochloride monohydrate, polysorbate 20, sucrose, water for injection.
Formulation: Ready-to-use intravenous solution.
How to Use & Dosage
Route: Intravenous (IV) infusion.
Initial Dose: 300mg IV, followed two weeks later by a second 300mg IV infusion.
Maintenance Dose: 600mg IV every 6 months (can be given as two 300mg infusions 2 weeks apart).
Infusion Time: Typically 2.5 hours for each 300mg infusion.
Pre-Medication: Patients are often given antihistamines, acetaminophen, and corticosteroids to reduce infusion-related reactions.
Important: Administration should be performed under medical supervision in a hospital or clinic setting.
Uses & Treatments
Ocrevus Ocrelizumab 300mg is primarily used for:
Relapsing-Remitting Multiple Sclerosis (RRMS) – Reduces relapse rates and delays disability progression.
Primary Progressive Multiple Sclerosis (PPMS) – Slows the progression of physical disability.
Off-label uses – Investigated in certain autoimmune disorders as determined by neurologists.
Advantages
Highly targeted therapy with specific action on CD20-positive B cells.
Significantly reduces relapse rates in RRMS.
Slows disease progression in PPMS.
Administered only twice a year after the initial dosing, reducing treatment burden.
Well-tolerated with a manageable safety profile.
Storage Conditions
Store at 2°C to 8°C (refrigerate).
Protect from light.
Do not freeze.
Use within 24 hours of vial opening if kept at room temperature.
Alternative Indian Brands for Ocrevus Ocrelizumab 300mg Injection
Ocrevex – Ocrelizumab 300mg
Ocreliz – Ocrelizumab 300mg
Ocrevium – Ocrelizumab 300mg
(Availability may vary depending on suppliers and regions.)
Purchase Today Online Ocrevus Ocrelizumab 300mg Injection – Fast Delivery GlobMedIndia
Buy Ocrevus Ocrelizumab 300mg injection online from GlobMedIndia. Fast and safe delivery of MS treatments to USA, UK, UAE, Australia, Europe, and Southeast Asia.
Looking to purchase Ocrevus Ocrelizumab 300mg injection online? GlobMedIndia provides authentic, high-quality MS therapy with fast and reliable delivery worldwide. Available for shipment to USA, United Kingdom, UAE, Australia, Europe, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, South Korea, Africa, Thailand, Vietnam, and other Middle East and Southeast Asian countries.
Our Ocrevus Ocrelizumab 300mg injection is perfect for patients with RRMS and PPMS, offering a safe, effective, and convenient treatment option. With our trusted service, patients can get globally sourced medications delivered to their doorstep quickly and securely.
Buy Ocrevus Ocrelizumab 300mg online
Order Ocrevus Ocrelizumab 300mg injection
Ocrevus 300mg for MS treatment
Ocrevus Ocrelizumab delivery worldwide
Anti-cancer and MS medicines online
Ocrevus Ocrelizumab alternative brands India
Call to Action:
Contact us today to order your Ocrevus Ocrelizumab 300mg injection!
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com
